Amplifyher Ventures

Thanks to our friend, Alexander Fleiss, for featuring Intellihealth and our #FlyteMedical employer program in #Connecticut as a model for the #future of #obesity #treatment. We're honored to be part of Rebellion Research news! ARTICLE: https://lnkd.in/eqD-v-VZ PHOTO CRED: Rebellion Research Sloan Saunders

It was a day of women at NY TECH WEEK by a16z! Here’s a snapshot: 👩⚕️ Future of Women's Health Roundtable - Longevity, AI, and an Election Year co-hosted with Emmeline Ventures 💡 Emmeline Ventures, Ema - The AI for Women, Celeste, and Lōvu Health explored the integration of AI in women's health, addressing vital issues such as data gaps, personalized treatments, and the ethical use of AI to enhance maternal healthcare and accessibility. 💡Synastry Capital, Portfolia, and the Center for Reproductive Rights tackled the adverse effects of restrictive policies, the role of the private sector in healthcare advocacy, and how democracy and innovation interact to shape effective policies. 🚀 Breaking Barriers: Transparent Talks Among Female Entrepreneurs & Investors co-hosted with The Female Founder Collective and Amplifyher Ventures 💡 The Female Founder Collective, Amplifyher Ventures, Live Tinted, and Hill House Home talked about overcoming the unique challenges faced by female founders and investors, including navigating Series A funding, to mastering product-market fit, and the value of experienced legal advice. 💡Sarah Fergusson Chambless spoke with Brooke Baldwin, former CNN reporter and author of the best-selling book "Huddle: How Women Unlock Their Collective Power" in a candid conversation about the importance of connection and finding your community. What inspired you? #NYTechWeek #InvestinWomen

I am excited to share that Gameto has closed a $33M Series B fundraising round, led by Two Sigma Ventures and RA Capital Management, with participation from existing investors Insight Partners, Future Ventures, and BOLD Capital Partners among others. Our investor group is also joined by Ingeborg Investments, Amplifyher Ventures, Stacey Bendet Eisner, Founder, CEO, and Creative Director of alice + olivia, and Chelsea M.R. Hirschhorn, Founder and CEO of Frida. This funding brings Gameto’s total capital raised to date to $73M. We are honored to have added the teams at Two Sigma, RA Capital, and others to our stellar investor base, and we are pleased to see increased investor confidence in our platform technology and a recognition of the pressing need for modern treatments in the historically underfunded women's health space, despite a challenging market. I believe that each small step we take in investing in women’s health can lead to a giant leap in medical breakthroughs and innovation. A fundraising round is not a milestone per se but a way to continue amplifying one’s work. I strongly believe that Gameto has strong foundational science, promising data, and a highly driven team and I am very excited about using these funds to continue amplifying our hard work. These funds will support our late stage clinical development in the United States, post-market surveillance outside the US, and the creation of a commercial operations function for our lead product candidate, Fertilo, which aims to improve IVF and egg freezing by reducing the number of hormone injections needed by maturing eggs outside the body in a dish. When I moved to New York City for the first time, I was considering my own egg freezing and I had a dream that a woman could freeze her eggs and do IVF without weeks of painful hormonal injections. It is unreal how far we have come. We have changed, learned a lot, and grown, but still have a long way to go.  This raise was a team effort and product of the hard work of all Gameto team members, board members and advisors. Martin Varsavsky, Dylan Morris, Maryanna Saenko, Teymour Boutros-Ghali, Dusan Perovic, Laura Stoppel, Peter Kolchinsky, Mira Kaufman, Anna Mason, Deena Shakir, Leslie Schrock, Kristina Simmons We are expanding the team now and currently looking for a Chief Medical Officer, Commercial Operations Lead, and a Science Writer, so check out our website career page if you are passionate about our mission and think you are a good fit for any of the open positions. Link to our full Series B press release here: https://lnkd.in/gYCQggzy

Exciting news! Oova has earned a spot on Fast Company's World Changing Ideas list! We are honored to be recognized alongside other trailblazing organizations that are actively making a positive impact on our world. #FCWorldChangingIdeasIncredible ⁠ View the full list: https://lnkd.in/eZQEnfTQ

Motherly's 7th Annual State of Motherhood Report launched today. The annual survey, with nearly 6,000 respondents, conveyed that today’s mothers continue to parent without adequate support. Key findings from this year include: Gen Z moms are signaling a continuing future birth rate decline: Today’s moms under 30 are 2 times as likely to NOT plan for more children than moms of the same age in 2019, citing financial, childcare, global, environmental and medical concerns (69% in 2024 vs. 35% in 2019). Childcare access and affordability issues continue to impact mothers’ ability to work: 66% of moms note that the stress and cost of childcare has made them consider leaving the workforce, up 14% from 2023. These sentiments are highest among Gen Z at 82%. One quarter of all moms report receiving regular financial support from their parents: Gen Z moms are twice as likely to have help from their parents compared to their own mothers' generations (Gen X+). In this election year, more than 85% of moms over 30 support federally mandated paid leave, regulation to address climate change, federally protected reproductive rights and increased gun control policies. Surprisingly, moms under 30 are 3x LESS likely to support the same policies, possibly signaling apathy. https://lnkd.in/dQd7maFM